Nektar Therapeutics to attend UBS and Jefferies investor conferences

NKTR•2026-11-11

Nektar Therapeutics will attend the UBS Global Biopharma Conference in London on Nov. 17, 2026, and the Jefferies Global Healthcare Conference there on Nov. 18, with fireside chats at both events.

Nektar Therapeutics to attend UBS and Jefferies investor conferences

1. Conference appearances

Related News

Loma Negra publishes 4Q25 earnings call transcript

EastGroup Properties to attend Nareit's REITworld annual conference

Senstar Technologies publishes Q3 2026 earnings call transcript

OR Royalties offers 3% discount under fourth-quarter dividend reinvestment plan

EnerSys declares quarterly dividend of $0.2875 per share